All coverage
Milestone note Jul 14, 2026

DeepSeek readies a China IPO filing and a new round at a reported $74B valuation

DeepSeek has begun IPO preparations — a mainland China filing as soon as late 2026 for a 2027 debut — while raising a new private round, now firmed up by Reuters at up to ¥50B at a ~¥500B (~$74B) valuation, weeks after its first external round ($7.4B).

DeepSeek has begun preparing for a mainland-China IPO, per Bloomberg: it is working with accountants to close its books by December, targeting a filing as soon as late 2026 or early 2027 for a 2027 debut. In parallel it is discussing a fresh private round — at least ¥10B — at a valuation of no less than ¥480B ($71B), only weeks after closing its first external financing ($7B at roughly $50B). Both the timing and terms could still change.

Update (2026-07-15): Reuters firms up the numbers — the new round targets up to ¥50B at a valuation of about ¥500B (~$74B), and puts the June round at $7.4B with a ¥450B post-money. Reuters also names the June backers: founder Liang Wenfeng (¥20B personally), Tencent (¥10B) and CATL (¥5B) as largest external holders, alongside China's national AI fund, NetEase, JD.com and others.

Why it matters

A $50B-to-$71B mark-up in weeks is the Chinese AI trade repricing in real time — and an onshore DeepSeek listing would give China's public markets their first frontier-lab champion, the AI analogue of Unitree's STAR debut in robotics. For US labs the significance is competitive financing: the price-cutter undercutting them is about to have public-market capital and a domestic retail base funding the discount.

What to watch

The filing venue and timing firming up, and whether the ≥$71B round closes at terms — the tell for how much mainland capital wants exposure.

Who's involved